HYPERtension Reduction Through WALKing Stairs Versus Brisk Walking

NCT06952348 · tracked via the Priya Life Science Sweden tracker

Sponsor

Karolinska Institutet

Phase

Not applicable

Started

2025-11-27

Last updated

2025-12-08

Condition(s) studied

Metabolic DiseaseCardiovascular DiseasesHypertensionObesity and Overweight

Investigational drug(s) / intervention(s)

Stair and brisk walking combinedBrisk walkingStandard care

Stair and brisk walking combined: See arms.

Brisk walking: See arms.

Standard care: See arms.

Study summary

This clinical trial investigates whether incorporating stair walking into daily routines improves physical health in adults at risk of lifestyle-related conditions such as hypertension, type 2 diabetes, and cardiovascular disease. Participants will be randomized into three groups: (1) stair walking combined with brisk walking, (2) brisk walking alone, and (3) a control group receiving standard lifestyle advice without specific exercise instructions, stratified by age (\<65 y/o, v \>=65) and site.

The primary objective is to assess whether the combination of stair and brisk walking leads to greater reductions in systolic blood pressure compared to brisk walking alone or standard care. Secondary outcomes include changes in cardiometabolic risk factors.

Participants in the stair walking group will be instructed to climb ≥250 steps per day (\~5.5 minutes/day or \~37.5 minutes/week), or complete an equivalent elevation via inclined slopes, along with ≥75 minutes of brisk walking per week. Those in the brisk walking group will walk ≥150 minutes per week. The control group will receive general lifestyle advice but no tailored physical activity goals or feedback.

Participants in both active groups will aim to double their baseline activity levels. Physical activity will be continuously monitored using wearable devices. The active groups will receive personalized feedback and motivational support throughout the 6-month intervention period.

If effective, this study may offer a simple, scalable, and low-cost intervention model for use in clinical and public health settings, emphasizing personalized goals, remote monitoring, and behavioral support.

Eligibility

Sex

ALL

Min age

35 Years

Max age

—

Healthy volunteers

Inclusion Criteria Men and women aged 35 years or older with increased cardiometabolic risk, defined by all of the following: 1. Clinically confirmed hypertension, with or without antihypertensive treatment, as documented in the Electronic Health Record (EHR). 2. Overweight or obesity, defined as BMI between 27 and 40. 3. Physically inactive lifestyle, defined as either: * Light intensity or inactive category on the Stanford Brief Activity Survey (SBAS), or * Light intensity or inactive category in the physical activity section of the Swedish National Board of Health and Welfare Lifestyle Questionnaire. Exclusion Criteria Medical contraindications to physical activity (based on FYSS 2021, p. 182): * Severe, symptomatic aortic stenosis * Acute pulmonary embolism, myocarditis, pericarditis, or systemic infection (e.g., fever, muscle pain, lymphadenopathy) * Suspected or known aortic dissection * Severe hypertension (Grade 3: SBP \>180 mmHg or DBP \>110 mmHg), regardless of symptoms * Unstable coronary artery disease (including unstable angina, suboptimally treated stable angina, or recent myocardial infarction \<8 weeks) * Symptomatic, uncontrolled arrhythmia * Symptomatic, uncontrolled heart failure Other exclusion criteria: * Implanted pacemaker or ICD * Pregnancy * Smartphone incompatibility with Fitrockr© app (iOS \<16 or Android OS \<10) * Inability to understand Swedish or English * Any condition that may interfere with protocol compliance (e.g., severe mental illness or cognitive impairment) * Inability to walk stairs

Primary outcome measure(s)

Systolic Blood Pressure (SBP) at 6 months — 6 months
Office systolic blood pressure (SBP) at 6-month follow-up, adjusted for baseline values. SBP is a validated and widely accepted surrogate marker for cardiovascular morbidity and mortality, as well as overall health risk.

Trial sites (4)

Facility	City	Region	Status
Karolinska Universitetssjukhuset Huddinge	Stockholm	Sweden	Not Yet Recruiting
Liljeholmen Primary Care Center	Stockholm	Sweden	Recruiting
Södersjukhuset	Stockholm	Sweden	Not Yet Recruiting
Södertälje sjukhus	Stockholm	Sweden	Not Yet Recruiting

More Karolinska Institutet trials in Sweden

Sensory Neurography and S2PD, a Test-Retest Study Active, not recruiting

Diagnostic and Prognostic Salivary Biomarkers in Chronic Muscle Pain Active, not recruiting

Brain Connectivity Marker for Alzheimer's Disease Recruiting

Feasibility, Acceptability, and Preliminary Effects of ISTDP for Personality Disorders in a Specialized Psychiatric Clinic Enrolling by invitation

Health-related Quality of Life in Chiari Malformation Type 1 - A National Cross-Sectional Patient Survey Enrolling by invitation

Other trials for the same condition

Analysis of Articular Biomarkers From Osteoarthritic Thumb Basal Joints Recruiting

Genetic Predisposition to High Blood Pressure Enrolling by invitation

Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE Recruiting

Prospective Urban Rural Epidemiology Study Recruiting

HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06952348 on ClinicalTrials.gov ↗ ← All trials in Sweden